Eloctate IV 4000, from Sanofi, contains Efflaloctocog alpha (genetically recombination), used to control and prevent bleeding episodes and for routine prophylaxis in hemophilia A. It is supplied as 4,000 IU 1 bottle with dissolving solution (YJ code: 6343442D8027).
Eloctate IV 4000
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →